Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort

Clinica Chimica Acta

Volumn 411, Issue 1-2, 2010, Pages 86-91

  Guéchot, Jérôme ^a   Lasnier, Elisabeth ^a   Sturm, Nathalie ^b,c   Paris, Adeline ^c   Zarski, Jean Pierre ^b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Blood marker; Diagnostic accuracy; Hepascore; Hepatitis C; Liver fibrosis

Indexed keywords

ALPHA 2 MACROGLOBULIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID;

ADULT; AGED; ALGORITHM; ANALYZER; ARTICLE; ASSAY; AUTOMATION; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NON INVASIVE MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AUTOMATION; COHORT STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

HEPATITIS C VIRUS; NUCLEOPOLYHEDROVIRUS;

EID: 70449519962     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.10.011     Document Type: Article

References (25)

1. Manning D.S., and Afdhal N.H. Diagnosis and quantification of fibrosis. Gastroenterology 134 (2008) 1670-1681
2. Castera L. Assessing liver fibrosis. Expert Rev Gastroenterol Hepatol 2 (2008) 541-552
3. Wai C.T., Greeson J.K., Fontana R.J., Kalbfleisch J.D., et al. A simple non invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
4. Forns X., Ampurdanes S., Llovet J.M., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
5. Imbert-Bismuth F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poinard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
6. Calès P., Oberti F., Mochalak S., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42 (2005) 1373-1381
7. Leroy V., Monier F., Bottari S., et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 99 (2004) 271-279
8. Rosenberg W.M.C., Voelker M., Thiel R., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 (2004) 1704-1713
9. Adams L.A., Bulsara M., Rossi E., et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51 (2005) 1867-1873
10. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
11. Haute Autorité de Santé. Méthodes non invasives de mesure de la fibrose/cirrhose hepatique - Avis sur les actes. December 2008. http://www.has-sante.fr.
12. Guéchot J., Edrief S., Lasnier E., and Küper R. Automated assay of hyaluronic acid in serum. Immunoanal Biol Spec 23 (2008) 148-152
13. Bedossa P., and Poynard T. An algorithm for grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
14. Poynard T., Halfon P., Castera L., et al. Standardization of ROC curve for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 53 (2007) 1615-1622
15. Leroy V., Hilleret M.N., Sturm N., et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in hepatitis C. J Hepatol 46 (2007) 775-782
16. Halfon P., Bacq Y., de Muret A., et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 46 (2007) 395-402
17. Becker L., Salameh W., Sferruzza A., et al. Validation of Hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastrenterol Hepatol 7 (2009) 696-701
18. Ghani M.G., Strader D.B., Thomas D.L., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49 (2009) 1335-1374
19. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
20. Rousselet M.C., Michalak S., Dupré F., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264
21. Regev A., Bertho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
22. Colloredo G., Guido M., Sonzogni A., and Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39 (2003) 239-244
23. Kettaneh A., Marcellin P., Douvin C., et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 46 (2007) 628-634
24. Bottero J., Lacombe K., Guéchot J., et al. Performance of eleven biomarkers for liver fibrosis assessment in HIV-hepatitis B virus co-infected patients. J Hepatol 50 (2009) 1074-1083
25. Cacoub P., Carrat F., Bedossa P., et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the Fibrotic Study - ANRS HC02. J Hepatol 48 (2008) 765-773